IBEX Limited growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +17.0%
EBITDA: +14.9%
EBIT: +21.6%
EPS: +45.5%
Free cash flow: +63.9%
Operating cash flow: +76.7%

Forward estimates

Revenue: +5.3%
EBITDA: +54.9%
EPS: +4.0%

Three-year CAGR

Revenue: +4.2%
EBITDA: +18.7%
EBIT: +31.2%
Net income: +19.8%
EPS: +28.6%
Free cash flow: +24.7%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.